Avendano M.D.
-
Biologics
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s…
Read More »